Edition:
United Kingdom

People: Shanghai Fosun Pharmaceutical Group Co Ltd (2196.HK)

2196.HK on Hong Kong Stock

23.05HKD
23 May 2019
Change (% chg)

HK$-0.90 (-3.76%)
Prev Close
HK$23.95
Open
HK$24.15
Day's High
HK$24.15
Day's Low
HK$23.00
Volume
2,207,181
Avg. Vol
3,713,452
52-wk High
HK$51.65
52-wk Low
HK$19.76

Wang, Kexin 

Mr. Wang Kexin has been serving as Senior Vice President in Shanghai Fosun Pharmaceutical (Group) Co., Ltd. since 2015. He was General Manager in a Beijing-based medicine company, Vice President in a Chongqing-based pharmaceutical company and a Shanghai-based medicine industry development company, as well as Chairman of the Board in a Beijing-based medicine business company.

Basic Compensation

Total Annual Compensation, CNY --
Restricted Stock Award, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY --
Fiscal Year Total, CNY 6,259,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Qiyu Chen

10,489,600

Fang Yao

8,397,800

Yifang Wu

5,992,100

Xiaohui Guan

3,214,700

Yuqing Chen

2,578,200

Aimin Hui

1,097,800
As Of  31 Dec 2017